Patents Examined by Brian Gulledge
  • Sulfate free clear personal cleansing composition comprising low inorganic salt
    Patent number: 11607373
    Abstract: A clear personal cleansing composition having an anionic surfactant, a cationic deposition polymer, an aqueous carrier and a level of inorganic salt of from about 0 to about 1 wt %. The composition is substantially free of sulfates and has a % T of greater than about 80%. The composition can further comprise amphoteric surfactants. The composition remains phase stable and minimizes coacervate formulation until after dilution with water.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: March 21, 2023
    Assignee: The Procter & Gamble Company
    Inventors: Brian Xiaoqing Song, Brooke Michele Cochran, Howard David Hutton, III, Andrei Sergeevich Bureiko, Peter Herbert Koenig
  • Aromatic-based polyetheramine alkoxylates
    Patent number: 11603436
    Abstract: The present disclosure provides a polyetheramine alkoxylate compound containing aromatic groups in the hydrophobe allowing the compound to exhibit unique functionality, high performance and low cost, but without the toxicity and/or skin and eye irritation problems associated with conventional polyetheramine compounds.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: March 14, 2023
    Assignee: HUNTSMAN Petrochemical LLC
    Inventor: Matthew T. Meredith
  • Readily absorbable copolymer compositions for high strength sutures having enhanced strength retention post-implantation
    Patent number: 11596709
    Abstract: Novel surgical sutures and novel medical devices made from novel semi-crystalline, glycolide-rich A-B-A triblock copolymers of glycolide and lactide, wherein said B-segment is a fully amorphous random copolymer of glycolide and lactide, for long term medical applications are disclosed. The novel polymer compositions are useful for long term absorbable surgical sutures, meshes and other medical devices, especially for patients with compromised healing. The novel sutures have improved properties and improved breaking strength retention, while still substantially absorbing within about a 120-day period post-implantation.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: March 7, 2023
    Assignee: Ethicon, Inc.
    Inventors: Dennis D. Jamiolkowski, Christopher DeFelice, Sasa Andjelic, Brian M. Kelly, Marc Wisnudel, Daniel Steiger, Gaoyuan Gavin Chen
  • Microcapsules for controlled delivery of an active pharmaceutical ingredient
    Patent number: 11590084
    Abstract: The present invention relates a microcapsule that comprises an active pharmaceutical ingredient and a polymeric shell comprised of polymeric materials such as polyether, polyester, polyamine, polyamide, polyurea, polyurethane, polythiocarbamate, and polythiocarbonate. The outer surface of shell comprises surface functional groups such as hydroxide, primary amine, carboxylic acid, or protected forms thereof. These surface functional groups may be reacted further with reactants to place specific organic groups on the surface of the microcapsule. Such microcapsules are prepared by a modified interfacial condensation polymerization.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: February 28, 2023
    Inventors: Roman Bielski, Zbigniew Janusz Witczak
  • Dual phase products
    Patent number: 11571375
    Abstract: A discrete dispensed product comprising a first portion; and a second portion at least partially surrounding the first portion provides a premium and distinct appearance to consumers.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: February 7, 2023
    Assignee: The Procter & Gamble Company
    Inventors: Joseph Michael Zukowski, Sudeep Chakravarty, Yu Wang, Suxuan Gong
  • Pharmaceutical resinate compositions and methods of making and using thereof
    Patent number: 11564918
    Abstract: Disclosed herein are pharmaceutical compositions having a mixture of at least one active agent and an ion exchange resin, such that the composition releases about 75% or more of the at least one active agent within about 1 hour as measured by in-vitro dissolution in a USP Apparatus 2 (paddle) at about 50 rpm in about 900 ml 0.1N HCl at about 37° C. and related methods. Also disclosed herein are pharmaceutical compositions having a mixture of a drug susceptible to abuse, a non-opioid analgesic and an ion exchange resin, the composition further including at least one gelling agent and related methods.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: January 31, 2023
    Assignee: RHODES PHARMACEUTICALS L.P.
    Inventors: Gerard P. Frunzi, Sibao Chen, Rajeev A. Jain
  • Tuning of release kinetics in hydrogels
    Patent number: 11559489
    Abstract: The present disclosure is directed to methods for tuning the release profile of a biologic disposed in a hydrogel. Parameters that can be used for the tuning include a molar ratio of a nucleophilic group to an electrophilic group, the number of the nucleophilic groups in the first precursor, the number of the electrophilic groups in the second precursor, the molecular weight of the first precursor, the molecular weight of the second precursor, a weight ratio of the biologic and excipient to the hydrogel, a weight percentage of the biologic in a solid state formulation, and a ratio of surface area to volume of the hydrogel. The methods described herein allow the formation of hydrogel with different release profiles suitable for different therapeutic applications.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: January 24, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Hunter Chen, Erica Schlesinger, James Feindt
  • Preparation method and use of artificial exosome complex
    Patent number: 11559477
    Abstract: A preparation method and use of an artificial exosome complex are provided. Raw materials for preparing the artificial exosome complex include linear polyethyleneimine (PEI) and hyaluronic acid (HA). The linear PEI can be obtained through the HA-PEI preparation process of the present disclosure, and most PEI is branched currently. According to the HA-PEI preparation method, HA-PEI with a specific molecular weight can be quantitatively prepared. The preparation process involves controllable operation steps, and thus can be used for large-scale industrial production. The prepared HA-PEI can promote the absorption of an encapsulated active substance by deep skin cells through the ligand activity of HA and the membrane permeability of linear PEI.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: January 24, 2023
    Assignee: SHANGHAI CHEERMORE BIOLOGICAL TECHNOLOGY CO., LTD.
    Inventors: Caibin Zhu, Junxiang Li
  • Drug loaded nanoresin particles
    Patent number: 11559487
    Abstract: The present invention relates to nano-resin particles that are suitable for pharmaceutical use and their use in the pharmaceutical field. The present invention provides nano-sized resin particles having a particle size distribution characterized in that D90 value is between 200 nanometers to 900 nanometer and D10 value is not less than 50 nanometers, wherein the nano-resin particles are in pure form and safe for pharmaceutical use. The present invention further relates to pharmaceutical compositions comprising these purified nano-resin particles and their use in the treatment of diseases.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: January 24, 2023
    Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
    Inventors: Ajay Jaysingh Khopade, Arindam Halder, Shivam Umeshkumar Upadhyay
  • Sprayable high viscosity cosmetic formulation
    Patent number: 11547641
    Abstract: The invention relates to an anhydrous cosmetic or dermatological formulation comprising a viscose lipid-containing preparation and propellant gas consisting essentially of one or more substances selected from hydrofluorocarbons, n-butane, isobutane and propane. The formulation permits application to the skin by spraying of an otherwise nonsprayable preparation. The formulation is free from readily volatile solvents, surfactants, and preferably free from silicones.
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: January 10, 2023
    Assignee: BEIERSDORF AG
    Inventors: Jonatan Scherer, David Winterstein, Heike Miertsch
  • Ecofriendly biofilm-disrupting antimicrobial formulations, their development, and their uses
    Patent number: 11547651
    Abstract: A skin care, wound care, or oral care device, comprising an essential oil stabilized into a polymerizable substance.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: January 10, 2023
    Assignee: Alira Health Boston LLC
    Inventor: Mitchell Corey Sanders
  • Stabilization of particles coated with non-amphoteric, quaternizable and water-soluble polymers using a dispersing component
    Patent number: 11540513
    Abstract: Described herein is an aqueous composition including particles coated with at least one non-amphoteric, quaternizable polymer which is water soluble at 20° C., and at least one dispersing component, where the dispersing component includes a dispersing agent selected from an amphiphilic graft polymer based on water-soluble polyalkylene oxides (A) as a graft base and side chains formed by polymerization of a vinyl ester component (B), the polymer having an average of ?1 graft site per 50 alkylene oxide units and a mean molar mass Mw of from 3000 to 100 000.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: January 3, 2023
    Assignee: BASF SE
    Inventors: Hans-Peter Seelmann-Eggebert, Joachim Bentele, Simon Poulton
  • Skin perfecting cosmetic compositions and methods of use
    Patent number: 11540997
    Abstract: Skin tightening compositions for application to the skin for providing an instantaneous and dramatic improvement to the appearance of skin. The skin tightening compositions typically include about 5 to about 45 wt. % or more of one or more hydrophobic film-forming polymers comprising acrylates/stearyl methacrylate copolymer; about 0.5 to about 20 wt. % of a mineral thickening agent; about 1 to about 15 wt. % of a silicone elastomer; and about 30 to about 85 wt. % of a volatile hydrocarbon oil, wherein all percentages by weight are based on the total weight of the skin tightening composition. Additionally, the skin tightening composition may have a weight ratio of the total amount of hydrophobic film-forming polymers to the total amount of mineral thickening agent is 1:1 to 10:1 and a weight ratio of the total amount of silicone elastomer to the total amount of mineral thickening agent is 1:2 to 8:1.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: January 3, 2023
    Assignee: L'OREAL
    Inventors: Alexandra Jane Elisa Farran, Prabhjot K. Saini
  • Bio-based and biodegradable elastomer for cosmetic and personal care
    Patent number: 11534389
    Abstract: A polyurethane elastomeric rubber composition containing a bio-based polyol cross-linked with a bio-based isocyanate using a urethanation catalyst such as a bismuth catalyst in the presence of a cosmetic emollient is disclosed. The cross-linked polyurethane elastomer rubber is in further aspect of the invention included in a gel after being milled in the presence of a bio-based emollient or mixture of bio-based emollients. The polyurethane elastomeric gel has good compatibility with cosmetic and natural oils and can be used as a gelling agent for these oils among other desirable cosmetic formulary roles.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: December 27, 2022
    Assignee: GRANT INDUSTRIES, INC
    Inventors: Anna K. Croom, Ronald V. Lerum, John Gormley
  • Dispersions comprising at least one non-volatile hydrocarbon oil
    Patent number: 11534390
    Abstract: A dispersion containing a dispersed phase comprising drops and a continuous aqueous phase, preferably in the form of gel, in which the drops comprise a fatty phase containing at least one gelling agent, and in which the fatty phase comprises at least one non-volatile hydrocarbon oil H1 containing more than 90%, and preferably more than 95%, fatty acids having at least 18 carbon atoms and preferably at least 20 carbon atoms.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: December 27, 2022
    Assignee: CAPSUM
    Inventors: Amélie Pujol, Hélène Balbusquier, Mathieu Goutayer
  • Biotechnologically-produced cellulose-containing article for dermatological use
    Patent number: 11529433
    Abstract: A cellulose-containing article for treating an area of skin, wherein the article comprises BNC in an amount of at least 1% by weight and at most 15% by weight, comprises fluid in an amount of at least 85% by weight and at most 99% by weight, has an average thickness of at least 0.5 mm and at most 8 mm, wherein the BNC is of microbial origin.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: December 20, 2022
    Assignee: JeNaCell GmbH
    Inventor: Nadine Hessler
  • Micelles and vesicles for the delivery of glycopeptides
    Patent number: 11504325
    Abstract: Methods for quality control and optimizing the formation and characterization of micelles, vesicles or other aggregates are described herein. Pharmaceutically relevant peptides may be modified to form glycopeptide surfactants which form micelles or other aggregates with another surfactant. Glycopeptide and glycolipid surfactants can aggregate to form particles that enhance drug delivery. The glycopeptide surfactants may be drugs or pro-drugs which are delivered via the micelles or other aggregated structures.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: November 22, 2022
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Robin L. Polt, Dillon Hanrahan, Lajos Z. Szabo, Michael L. Heien, Chenxi Liu
  • Multi-functional anti-microbial polymers and compositions containing same
    Patent number: 11497701
    Abstract: The present disclosure relates to multi-functional anti-microbial polymers comprising a first monomer having a polymerizable cyclic aromatic moiety which forms part of the backbone of the polymer and a second monomer having an ethylenically unsaturated monomer having a double or triple bond and a quaternary ammonium or quaternary phosphonium moiety.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: November 15, 2022
    Assignee: CHEMGREEN INNOVATION INC.
    Inventors: Khashayar Ghandi, Zahid Mahimwalla, Michael Kairiss, Yang Tan, Felix Baerlocher
  • Removable film forming gel compositions featuring adhesion promoters
    Patent number: 11497828
    Abstract: Film-forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film-forming polymer, an amine-rich adhesion promoter, and a volatile solvent. The gel compositions form relatively thick films when dried on tissue, and can exhibit enhanced breathability to promote wound healing.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: November 15, 2022
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Katie F. Wlaschin, George W. Griesgraber, Alexi J. Young, Semra Colak Atan, Delony L. Langer-Anderson, Junia M. Pereira, Michael J. Solberg
  • Hemostatic devices and methods of use
    Patent number: 11471570
    Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: October 18, 2022
    Assignee: MEDTRONIC, INC.
    Inventors: Satish Pulapura, Fatima Buevich, Jorie S. Soskin, Franklin R. Mansfield, Kai R. Worrell, Charlie Wood, Jorge Alberto Trevino Blanco, Narvel M. Brooks, III